Alithya trimmed its loss to $15.5 million for the most recently completed year, down from a loss of $17.4 million for fiscal 2021. Revenue rose to $437.9 million for fiscal 2022, up 52.2 percent from $287.6 million the prior year. In the recent earnings webcast, CEO Paul Raymond noted the U.S. performance, whose revenue increased to $41.3 million came in its manufacturing and health care verticals and included $5 million from two months of operations of the acquired Vitalsyt. Additional revenue for fiscal 2023 will include Datum Consulting Group, which was expected to close on July 1. Dataum, which was purchased for up to $56.4 million, had $18 million in revenue for the year ended December. Alithya is continuing to hire actively anticipating more capacity in India and Eastern Europe through the acquisition of Datum. Raymond said the opening of new operations in Morocco means “we can hire a lot of full-time people there. So that's going to reduce our reliance on subcontractors.” The company, he said, has a staff of 80 recruiters for global hiring. Alithya ranked No. 2 on Bob Scott’s Top 100 VARs for 2022. That ranking showed revenue of $395.9 million for 2022, reflecting sales for the fourth quarter ended March 31 2021, combined with the nine months ended December 31 for 12 months of revenue.